US Congress passes bill that reauthorises the FDA’s paediatric priority voucher pathway for five more years

The research program ILP101 Inhale receives funding for in vivo proof-of-concept testing from The Swedish Cystic Fibrosis Association

House passes bill that reauthorises the FDA’s paediatric priority voucher pathway

Ilya Pharma selected to present at 27th Annual SoCalBio Investor and Partnering Conference October 1-2 in Newport Beach

Ilya Pharma recieves decision to grant from European Patent Office for its second patent covering the ILP-drug candidates and their use in skin and mucosa in humans and animals

Ilya Pharma will be attending the Accelerating Bio-Innovation in Boston June 22-25.

Ilya Pharma participates at SIN UK-Northern Europe Panel on "Galvanising AMR Financing" Nov 27, British Ambassadors Residence

Stefan Roos presents at Apotekarsociteten seminar of live bacteria as pharmaceuticals November 27, online

Ilya Pharma participates in Global Scale Up program Powered by Health~Holland, Top Sector Life Sciences & Health

The Scale-up Investor Ready Program prepares entrepreneurs for the transatlantic investor market and increases the chances of successful financing.

Ilya Pharma will present poster of non-clinical data of ILP100-Oral at IBD Nordic Conference November 27-29, Malmö